Table 1.
Baseline characteristics.
| Variables | Subgroups | BioIntegral (n = 73) | LABCOR (n = 193) | p |
|---|---|---|---|---|
| Age (years) | total | 69.0 (59.0; 75.0) | 66.0 (57.0; 74.5) | 0.228 |
| endocarditis | 71.0 (60.0; 76.0) | 62.5 (52.8; 71.5) | 0.067 | |
| no endocarditis | 67.5 (54.5; 73.3) | 66.0 (57.0; 75.0) | 0.699 | |
| Male (%) | total | 64.4 | 68.4 | 0.534 |
| endocarditis | 63.6 | 83.3 | 0.310 | |
| no endocarditis | 66.7 | 67.4 | 0.949 | |
| Body mass index | total | 25.9 (23.7; 28.7) | 27.2 (24.5; 29.9) | 0.119 |
| endocarditis | 25.9 (23.6; 28.7) | 28.6 (25.2; 34.0) | 0.116 | |
| no endocarditis | 26.7 (23.8; 30.2) | 27.2 (24.4; 29.7) | 0.891 | |
| Arterial hypertension (%) | total | 76.7 | 67.9 | 0.159 |
| endocarditis | 81.8 | 58.3 | 0.121 | |
| no endocarditis | 61.1 | 68.5 | 0.522 | |
| Hyperlipidemia (%) | total | 34.2 | 27.5 | 0.278 |
| endocarditis | 32.7 | 33.3 | 1.000 | |
| no endocarditis | 38.9 | 27.1 | 0.288 | |
| Diabetes mellitus (%) | total | 21.9 | 6.7 | <0.001 |
| endocarditis | 23.6 | 0.0 | 0.104 | |
| no endocarditis | 16.7 | 7.2 | 0.164 | |
| Smoker (%) | total | 21.9 | 19.2 | 0.617 |
| endocarditis | 20.0 | 33.3 | 0.444 | |
| no endocarditis | 27.8 | 18.2 | 0.347 | |
| Chronic obstructive lung disease (%) | total | 12.3 | 11.9 | 0.927 |
| endocarditis | 12.7 | 16.7 | 0.658 | |
| no endocarditis | 11.1 | 11.6 | 1.000 | |
| Pulmonary hypertension (%) | total | 9.6 | 8.8 | 0.843 |
| endocarditis | 9.1 | 0.0 | 0.576 | |
| no endocarditis | 11.1 | 9.4 | 0.684 | |
| Renal insufficiency (%) | total | 35.6 | 22.8 | 0.034 |
| endocarditis | 43.6 | 41.7 | 0.901 | |
| no endocarditis | 11.1 | 21.5 | 0.376 | |
| Dialysis (%) | total | 2.7 | 2.6 | 1.000 |
| endocarditis | 1.8 | 8.3 | 0.328 | |
| no endocarditis | 5.6 | 2.2 | 0.381 | |
| Peripheral artery disease (%) | total | 1.4 | 2.1 | 1.000 |
| endocarditis | 0.0 | 16.7 | 0.030 | |
| no endocarditis | 5.6 | 1.1 | 0.249 | |
| Malignom in history (%) | total | 9.6 | 12.4 | 0.519 |
| endocarditis | 10.9 | 8.3 | 1.000 | |
| no endocarditis | 5.6 | 12.7 | 0.703 | |
| Stroke in history (%) | total | 8.2 | 5.2 | 0.389 |
| endocarditis | 9.1 | 0.0 | 0.576 | |
| no endocarditis | 5.6 | 5.5 | 1.000 | |
| Coronary heart disease (%) | total | 46.6 | 40.4 | 0.364 |
| endocarditis | 52.7 | 66.7 | 0.379 | |
| no endocarditis | 27.8 | 38.7 | 0.363 | |
| Previous myocardial infarction (%) | total | 9.6 | 9.8 | 0.950 |
| endocarditis | 9.1 | 8.3 | 1.000 | |
| no endocarditis | 11.1 | 9.9 | 0.699 | |
| Previous coronary stenting (%) | total | 13.7 | 9.8 | 0.368 |
| endocarditis | 16.4 | 16.7 | 1.000 | |
| no endocarditis | 5.6 | 9.4 | 1.000 | |
| Previous cardiac surgery (%) | total | 86.3 | 16.6 | <0.001 |
| endocarditis | 96.4 | 58.3 | 0.001 | |
| no endocarditis | 55.6 | 13.8 | <0.001 | |
| Pacemaker (%) | total | 21.9 | 2.1 | <0.001 |
| endocarditis | 23.6 | 0.0 | 0.104 | |
| no endocarditis | 16.7 | 2.2 | 0.017 | |
| Paroxysmal atrial fibrillation (%) | total | 20.5 | 16.1 | 0.388 |
| endocarditis | 21.8 | 8.3 | 0.435 | |
| no endocarditis | 16.7 | 16.6 | 1.000 | |
| Non-paroxysmal atrial fibrillation (%) | total | 11.0 | 12.4 | 0.741 |
| endocarditis | 14.5 | 16.7 | 1.000 | |
| no endocarditis | 0.0 | 12.2 | 0.230 | |
| EuroSCORE II (%) | total | 14.9 (7.1; 25.0) | 4.1 (1.6; 12.0) | <0.001 |
| endocarditis | 16.1 (9.6; 27.5) | 9.1 (3.3; 20.8) | 0.050 | |
| no endocarditis | 5.3 (3.3; 17.1) | 3.9 (1.5; 12.0) | 0.115 |